These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 33128792)

  • 1. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
    Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
    Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
    Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
    Front Immunol; 2021; 12():636768. PubMed ID: 33777028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
    Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19.
    Kratzer B; Gattinger P; Trapin D; Ettel P; Körmöczi U; Rottal A; Stieger RB; Sehgal ANA; Feichter M; Borochova K; Tulaeva I; Grabmeier-Pfistershammer K; Tauber PA; Perkmann T; Fae I; Wenda S; Kundi M; Fischer GF; Valenta R; Pickl WF
    Allergy; 2024 Sep; 79(9):2482-2501. PubMed ID: 39003594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19.
    Jörrißen P; Schütz P; Weiand M; Vollenberg R; Schrempf IM; Ochs K; Frömmel C; Tepasse PR; Schmidt H; Zibert A
    Front Immunol; 2021; 12():679841. PubMed ID: 34421894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
    Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.
    Stanczak MA; Sanin DE; Apostolova P; Nerz G; Lampaki D; Hofmann M; Steinmann D; Krohn-Grimberghe M; Thimme R; Mittler G; Waller CF; Pearce EJ; Pearce EL
    Nat Commun; 2021 Apr; 12(1):2133. PubMed ID: 33837219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection.
    Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
    Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
    Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-the-Shelf Partial HLA Matching SARS-CoV-2 Antigen Specific T Cell Therapy: A New Possibility for COVID-19 Treatment.
    Kim N; Lee JM; Oh EJ; Jekarl DW; Lee DG; Im KI; Cho SG
    Front Immunol; 2021; 12():751869. PubMed ID: 35003063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.